icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
Real World Effectiveness of Ledipasvir/Sofosbuvir in Treatment-Experienced Cirrhotic Genotype 1 Patients with Chronic HCV: A Comparative Analysis of Gilead Sponsored Trials with 4 Real-World Cohorts
  Reported by Jules Levin
EASL 2016 April 14-27 Barcelona
M Curry1, AA Modi2,S Pungpapong3, M Leise4, B Aqel5, J Llewellyn6, J Zhang6, L Williams6, M Natha6, B Kreter6, J McNally6, DM Brainard6, A Kohli7, D Wyles8, Y Lee9, R Reddy10 1Beth Israel Deaconess, Boston, MA; 2Baylor Scott and White, Fort Worth, TX; 3Mayo Clinic, FL; 4Mayo Clinic, MN 5Mayo Clinic, AZ; 6Gilead Sciences Foster City, CA; 7Creighton University, SJHMC, Phoenix, AZ; 8University of California, San Diego, CA; 9TRIO Health Analytics; 10University of Pennsylvania, PA